Juan
Dubrot Armendáriz
Profesional Investigador
Carlos
Alfaro Alegría
Investigador hasta 2017
Publicaciones en las que colabora con Carlos Alfaro Alegría (18)
2012
-
Cardiotrophin-1 determines liver engraftment of syngenic colon carcinoma cells through an immune system-mediated mechanism
OncoImmunology, Vol. 1, Núm. 9, pp. 1527-1536
-
Liver Gene Transfer of Interkeukin-15 Constructs That Become Part of Circulating High Density Lipoproteins for Immunotherapy
PLoS ONE, Vol. 7, Núm. 12
2011
-
Carcinoma-derived Interleukin-8 disorients dendritic cell migration without impairing T-cell stimulation
PLoS ONE, Vol. 6, Núm. 3
-
Intratumoral injection of interferon-α and systemic delivery of agonist anti-CD137 monoclonal antibodies synergize for immunotherapy
International Journal of Cancer, Vol. 128, Núm. 1, pp. 105-118
-
Synergistic effects of CTLA-4 blockade with tremelimumab and elimination of regulatory T lymphocytes in vitro and in vivo
International Journal of Cancer, Vol. 129, Núm. 2, pp. 374-386
2010
-
Dendritic cells adhere to and transmigrate across lymphatic endothelium in response to IFN-α
European Journal of Immunology, Vol. 40, Núm. 11, pp. 3054-3063
-
Intensive pharmacological immunosuppression allows for repetitive liver gene transfer with recombinant adenovirus in nonhuman primates
Molecular Therapy, Vol. 18, Núm. 4, pp. 754-765
-
Interferon producing killer dendritic cells (IKDC): A matter of controversy
Inmunologia, Vol. 29, Núm. 1, pp. 50-55
-
Treatment with anti-CD137 mAbs causes intense accumulations of liver T cells without selective antitumor immunotherapeutic effects in this organ
Cancer Immunology, Immunotherapy, Vol. 59, Núm. 8, pp. 1223-1233
2009
-
In vivo depletion of DC impairs the anti-tumor effect of agonistic anti-CD137 mAb
European Journal of Immunology, Vol. 39, Núm. 9, pp. 2424-2436
-
Influence of bevacizumab, sunitinib and sorafenib as single agents or in combination on the inhibitory effects of VEGF on human dendritic cell differentiation from monocytes
British Journal of Cancer, Vol. 100, Núm. 7, pp. 1111-1119
2008
-
Interleukin-15 liver gene transfer increases the number and function of IKDCs and NK cells
Gene Therapy, Vol. 15, Núm. 7, pp. 473-483
-
Therapeutic antitumor efficacy of anti-CD137 agonistic monoclonal antibody in mouse models of myeloma
Clinical Cancer Research, Vol. 14, Núm. 21, pp. 6895-6906
2007
-
Absence of surface expression of CD137 (4-1BB) on Myeloid-derived suppressor cells
Inmunologia, Vol. 26, Núm. 3, pp. 121-126
-
Cellular liaisons of natural killer lymphocytes in immunology and immunotherapy of cancer
Expert Opinion on Biological Therapy, Vol. 7, Núm. 5, pp. 599-615
-
Immunotherapy and immunoescape in colorectal cancer
World Journal of Gastroenterology, Vol. 13, Núm. 44, pp. 5822-5831
-
The combined actions of NK and T lymphocytes are necessary to reject an EGFP+ mesenchymal tumor through mechanisms dependent on NKG2D and IFNγ
International Journal of Cancer, Vol. 121, Núm. 6, pp. 1282-1295
2006
-
Immunogenic cell death and cross-priming are reaching the clinical immunotherapy arena
Clinical Cancer Research